Amelia is a registered clinical scientist working at the Royal Brompton Hospital, London, where she leads the scientific service for the diagnosis of Primary Ciliary Dyskinesia (PCD).
PCD is an inherited condition affecting 1 in 20,000 people in the UK (www.pcdsupport.org.uk). Cilia are small organelles which line the surface of the nose and lungs. Their job is to clear mucus and protect the airways from infection. Amelia’s research interests concern the improvement of diagnosis and management for patients with ciliary dysfunction. Her research is funded by a NIHR fellowship.
Amelia lectures at Imperial College and supervises MSc and BSc students.
et al., 2017, Lung Clearance Index (LCI) is Stable in Most Primary Ciliary Dyskinesia (PCD) Patients Managed in a Specialist Centre: a Pilot Study., Lung
et al., 2017, European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia, European Respiratory Journal, Vol:49, ISSN:0903-1936
et al., 2017, BMI-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity, American Journal of Physiology-lung Cellular and Molecular Physiology, Vol:312, ISSN:1040-0605, Pages:L258-L267
et al., 2017, X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3, Nature Communications, Vol:8, ISSN:2041-1723
et al., 2017, Accuracy of Immunofluorescence in the Diagnosis of Primary Ciliary Dyskinesia, American Journal of Respiratory and Critical Care Medicine, Vol:196, ISSN:1073-449X, Pages:94-101